IRIS Accounts Production v26.1.0.640 05804366 Board of Directors 1.4.25 30.4.26 30.4.26 false true false false true false Ordinary Ordinary iso4217:GBP iso4217:USD iso4217:EUR xbrli:shares xbrli:pure utr:tonnes utr:kWh 05804366 2025-03-31 05804366 2026-04-30 05804366 2025-04-01 2026-04-30 05804366 2024-03-31 05804366 2024-04-01 2025-03-31 05804366 2025-03-31 05804366 ns15:EnglandWales 2025-04-01 2026-04-30 05804366 ns14:PoundSterling 2025-04-01 2026-04-30 05804366 ns10:Director1 2025-04-01 2026-04-30 05804366 ns10:PrivateLimitedCompanyLtd 2025-04-01 2026-04-30 05804366 ns10:SmallEntities 2025-04-01 2026-04-30 05804366 ns10:AuditExemptWithAccountantsReport 2025-04-01 2026-04-30 05804366 ns10:SmallCompaniesRegimeForDirectorsReport 2025-04-01 2026-04-30 05804366 ns10:SmallCompaniesRegimeForAccounts 2025-04-01 2026-04-30 05804366 ns10:FullAccounts 2025-04-01 2026-04-30 05804366 ns10:OrdinaryShareClass1 2025-04-01 2026-04-30 05804366 ns10:OrdinaryShareClass2 2025-04-01 2026-04-30 05804366 ns10:OrdinaryShareClass3 2025-04-01 2026-04-30 05804366 ns10:Director2 2025-04-01 2026-04-30 05804366 ns10:Director3 2025-04-01 2026-04-30 05804366 ns10:Director4 2025-04-01 2026-04-30 05804366 ns10:CompanySecretary1 2025-04-01 2026-04-30 05804366 ns10:RegisteredOffice 2025-04-01 2026-04-30 05804366 ns5:CurrentFinancialInstruments 2026-04-30 05804366 ns5:CurrentFinancialInstruments 2025-03-31 05804366 ns5:ShareCapital 2026-04-30 05804366 ns5:ShareCapital 2025-03-31 05804366 ns5:RetainedEarningsAccumulatedLosses 2026-04-30 05804366 ns5:RetainedEarningsAccumulatedLosses 2025-03-31 05804366 ns5:PlantMachinery 2025-04-01 2026-04-30 05804366 ns10:OrdinaryShareClass1 2024-04-01 2025-03-31 05804366 ns5:PlantMachinery 2025-03-31 05804366 ns5:PlantMachinery 2026-04-30 05804366 ns5:PlantMachinery 2025-03-31 05804366 ns5:WithinOneYear ns5:CurrentFinancialInstruments 2026-04-30 05804366 ns5:WithinOneYear ns5:CurrentFinancialInstruments 2025-03-31

REGISTERED NUMBER: 05804366 (England and Wales)

Report of the Directors and

Unaudited Cessation Financial Statements

for the Period 1 April 2025 to 30 April 2026

for

XLNT (HEALTH) LIMITED

XLNT (HEALTH) LIMITED (REGISTERED NUMBER: 05804366)

Contents of the Financial Statements

for the Period 1 April 2025 to 30 April 2026

Page |

Company Information | 1 |

Report of the Directors | 2 |

Chartered Accountants' Report | 3 |

Income Statement | 4 |

Balance Sheet | 5 |

Notes to the Financial Statements | 6 |

XLNT (HEALTH) LIMITED

Company Information

for the Period 1 April 2025 to 30 April 2026

| DIRECTORS: | M A P Cattini

| P Labadini

| L D Cattini

| M Labadini

| SECRETARY: | M A P Cattini

| REGISTERED OFFICE: | C/O Hill Wooldridge & Co

| Monument House

| 215 Marsh Road

| Pinner

| HA5 5NE

| BUSINESS ADDRESS: | Whittington Hospital

| 1st Floor

| Magdala Avenue

| London

| N19 5NF

| REGISTERED NUMBER: | 05804366 (England and Wales)

| ACCOUNTANTS: | Hill Wooldridge & Co.

| Monument House

| 215 Marsh Road

| Pinner

| HA5 5NE

XLNT (HEALTH) LIMITED (REGISTERED NUMBER: 05804366)

Report of the Directors

for the Period 1 April 2025 to 30 April 2026

The directors present their report with the financial statements of the company for the period 1 April 2025 to 30 April 2026.

CESSATION OF TRADING

The company ceased trading on 30 April 2026.

PRINCIPAL ACTIVITY

The principal activity of the company in the period under review was that of catering services.

DIRECTORS

The directors shown below have held office during the whole of the period from 1 April 2025 to the date of this report.

M A P Cattini

P Labadini

L D Cattini

M Labadini

STATEMENT OF DIRECTORS' RESPONSIBILITIES

The directors are responsible for preparing the Report of the Directors and the financial statements in accordance with applicable law and regulations.

Company law requires the directors to prepare financial statements for each financial year. Under that law the directors have elected to prepare the financial statements in accordance with United Kingdom Generally Accepted Accounting Practice (United Kingdom Accounting Standards and applicable law). Under company law the directors must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the company and of the profit or loss of the company for that period. In preparing these financial statements, the directors are required to:

- | select suitable accounting policies and then apply them consistently;

- | make judgements and accounting estimates that are reasonable and prudent;

- | prepare the financial statements on the going concern basis unless it is inappropriate to presume that the company will continue in business.

The directors are responsible for keeping adequate accounting records that are sufficient to show and explain the company's transactions and disclose with reasonable accuracy at any time the financial position of the company and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.

This report has been prepared in accordance with the provisions of Part 15 of the Companies Act 2006 relating to small companies.

ON BEHALF OF THE BOARD:

M A P Cattini - Director

5 June 2026

Chartered Accountants' Report to the Board of Directors

on the Unaudited Financial Statements of

XLNT (Health) Limited

In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the financial statements of XLNT (Health) Limited for the period ended 30 April 2026 which comprise the Income Statement, Balance Sheet and the related notes from the company's accounting records and from information and explanations you have given us.

As a practising member firm of the Institute of Chartered Accountants in England and Wales (ICAEW), we are subject to its ethical and other professional requirements which are detailed within the ICAEW's regulations and guidance at http://www.icaew.com/en/membership/regulations-standards-and-guidance.

This report is made solely to the Board of Directors of XLNT (Health) Limited, as a body, in accordance with our terms of engagement. Our work has been undertaken solely to prepare for your approval the financial statements of XLNT (Health) Limited and state those matters that we have agreed to state to the Board of Directors of XLNT (Health) Limited, as a body, in this report in accordance with ICAEW Technical Release 07/16AAF. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than XLNT (Health) Limited and its Board of Directors, as a body, for our work or for this report.

It is your duty to ensure that XLNT (Health) Limited has kept adequate accounting records and to prepare statutory financial statements that give a true and fair view of the assets, liabilities, financial position and profit of XLNT (Health) Limited. You consider that XLNT (Health) Limited is exempt from the statutory audit requirement for the period.

We have not been instructed to carry out an audit or a review of the financial statements of XLNT (Health) Limited. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory financial statements.

Hill Wooldridge & Co.

Monument House

215 Marsh Road

Pinner

HA5 5NE

5 June 2026

XLNT (HEALTH) LIMITED (REGISTERED NUMBER: 05804366)

Income Statement

for the Period 1 April 2025 to 30 April 2026

| Period |

| 1.4.25 |

| to |  | Year Ended

| 30.4.26 |  | 31.3.25

| Notes | £ | £ |

TURNOVER | 523,293 |  | 575,145 |  |

Cost of sales | 206,563 |  | 213,657 |  |

GROSS PROFIT | 316,730 |  | 361,488 |  |

Administrative expenses | 317,415 |  | 279,251 |  |

OPERATING (LOSS)/PROFIT | (685 | ) | 82,237 |  |

Interest receivable and similar income | 4,915 |  | 6,449 |  |

4,230 |  | 88,686 |  |

Interest payable and similar expenses | - |  | 39 |  |

PROFIT BEFORE TAXATION | 4,230 |  | 88,647 |  |

Tax on profit | 1,188 |  | 19,744 |  |

PROFIT FOR THE FINANCIAL PERIOD | 3,042 |  | 68,903 |  |

XLNT (HEALTH) LIMITED (REGISTERED NUMBER: 05804366)

Balance Sheet

30 April 2026

| 2026 | 2025 |

| Notes | £ | £ | £ | £ |

FIXED ASSETS

Tangible assets | 5 | - |  | 1,892 |  |

CURRENT ASSETS

Stocks | - |  | 7,050 |  |

Debtors | 6 | 1,999 |  | 4,048 |  |

Cash at bank and in hand | 170,695 |  | 237,057 |  |

172,694 |  | 248,155 |  |

CREDITORS

Amounts falling due within one year | 7 | 1,516 |  | 57,911 |  |

NET CURRENT ASSETS | 171,178 |  | 190,244 |  |

TOTAL ASSETS LESS CURRENT LIABILITIES | 171,178 |  | 192,136 |  |

CAPITAL AND RESERVES

Called up share capital | 100 |  | 100 |  |

Retained earnings | 171,078 |  | 192,036 |  |

SHAREHOLDERS' FUNDS | 171,178 |  | 192,136 |  |

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the period ended 30 April 2026.

The members have not required the company to obtain an audit of its financial statements for the period ended 30 April 2026 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:

(a) | ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and

(b) | preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved by the Board of Directors and authorised for issue on 5 June 2026 and were signed on its behalf by:

M A P Cattini - Director

XLNT (HEALTH) LIMITED (REGISTERED NUMBER: 05804366)

Notes to the Financial Statements

for the Period 1 April 2025 to 30 April 2026

1. | STATUTORY INFORMATION

| XLNT (Health) Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. | ACCOUNTING POLICIES

| Basis of preparing the financial statements

| These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

| Turnover

| Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

| Tangible fixed assets

| Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.

| Plant and machinery etc | - | 25% on reducing balance

| Stocks

| Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

| Taxation

| Taxation for the period comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

| Current or deferred taxation assets and liabilities are not discounted.

| Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

| Deferred tax

| Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

| Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the period end and that are expected to apply to the reversal of the timing difference.

| Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

| Hire purchase and leasing commitments

| Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

| Pension costs and other post-retirement benefits

| The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3. | EMPLOYEES AND DIRECTORS

| The average number of employees during the period was 8 (2025 - 8 ) .

XLNT (HEALTH) LIMITED (REGISTERED NUMBER: 05804366)

Notes to the Financial Statements - continued

for the Period 1 April 2025 to 30 April 2026

4. | DIVIDENDS

| Period |

| 1.4.25 |

| to | Year Ended

| 30.4.26 |  | 31.3.25

£ | £ |

| Ordinary shares of £1 each

| Interim | 24,000 |  | 102,333 |  |

5. | TANGIBLE FIXED ASSETS

| Plant and

| machinery

| etc

£ |

| COST

| At 1 April 2025 | 98,611 |  |

| Disposals | (98,611 | ) |

| At 30 April 2026 | - |  |

| DEPRECIATION

| At 1 April 2025 | 96,719 |  |

| Eliminated on disposal | (96,719 | ) |

| At 30 April 2026 | - |  |

| NET BOOK VALUE

| At 30 April 2026 | - |  |

| At 31 March 2025 | 1,892 |  |

6. | DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR |

2026 | 2025 |

£ | £ |

| Other debtors | 1,999 |  | 4,048 |  |

7. | CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR |

2026 | 2025 |

£ | £ |

| Taxation and social security | 1,516 |  | 35,725 |  |

| Other creditors | - |  | 22,186 |  |

1,516 |  | 57,911 |  |

8. | RELATED PARTY DISCLOSURES

| During the year, the company operated a loan account with the directors. At the balance sheet date the company owed the directors £Nil (2025: £6,400).

| During the year, the company issued dividends of £24,000 to the directors (2025: £102,333).